Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump.
D000818:Animals; D002116:Calcitonin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D002118:Calcium / Q000097:blood*; D004351:Drug Resistance; D007263:Infusions, Parenteral / Q000295:instrumentation*; D007279:Injections, Subcutaneous / Q000295:instrumentation*; D008297:Male; D009994:Osmolar Concentration; D010281:Parathyroid Hormone / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D010758:Phosphorus / Q000097:blood; D051381:Rats; D013997:Time Factors
D010281:Parathyroid Hormone; D010758:Phosphorus; D002116:Calcitonin; D002118:Calcium